5/21/2025

Phenytoin Oral Suspension

Products Affected - Description

- Phenytoin oral suspension, Mylan (Viatris), 125 mg/5 mL, 237 mL bottle, NDC 59762-0531-02
- Phenytoin oral suspension, Mylan (Viatris), 125 mg/5 mL, 240 mL bottle, NDC 59762-0531-01
- Phenytoin oral suspension, Sun Pharma, 125 mg/5 mL, 237 mL bottle, NDC 51672-4069-01

Reason for the Shortage

- Viatris did not provide a reason for the shortage. Dilantin-125 oral suspension is available.
- Sun Pharma did not provide a reason for the shortage.

Available Products

- Dilantin-125 oral suspension, Mylan (Viatris), 125 mg/5 mL, 237 mL bottle, NDC 58151-0115-35

Estimated Resupply Dates

- Sun Pharma has phenytoin 125 mg/5 mL oral suspension in 8 ounce bottles on back order and the company cannot estimate a release date.
- Viatris has phenytoin 125 mg/5 mL oral suspension in 8 ounce bottles on back order and the company cannot estimate a release date.

Updated

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.